Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zymeworks Inc. announced new clinical data for the HER2-targeted bispecific antibody, zanidatamab, in heavily pretreated HER2-positive breast cancer. The data are being presented at the San Antonio... | December 10, 2021
Let’s start up with the current stock price of Zymeworks Inc. (ZYME), which is $16.12 to be very precise. The Stock rose vividly during the last session to $19.00 after opening rate of $18.75 while the lowest price it went was recorded $16.02 before closing at $18.95.Recently in News on December 9
VANCOUVER, British Columbia--(BUSINESS WIRE)--Dec 9, 2021--
The Omicron variant concerns were front and center in the markets in the week ended Dec. 3, and ...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.